Pyogenic liver abscess: incidence, causality, management and clinical outcomes in a New Zealand cohort.
The determinants, management and outcomes of pyogenic liver abscess [PLA] are changing. We aimed to compare these in a New Zealand cohort. We have retrospectively reviewed all PLA cases presenting to Christchurch Hospital over 12 months between 2014 and 2015. Twenty-five cases presented over this period. The incidence was 5/100,000. Eighty percent were Caucasian with overall 4:1 male preponderance. Commonest comorbidities were diabetes, hypertension, atrial fibrillation and immunosuppression. Underlying pancreatico-biliary disease featured in 20%, preceding Whipple's or hepatic resection in 24% and inflammatory bowel disease [IBD] in 12%. Commonest complication was septic shock with intensive care unit admission in four cases. The evident cause was recent Whipple's procedure or hepatic resection (24%), pancreatico-biliary (16%), diverticulitis (12%) and active IBD (8%). Cause remained cryptogenic in 28%. The commonest microorganism was Streptococcus intermedius. The management comprised of: antibiotics alone (n=6), needle aspiration (n=2), catheter drainage (n=14), biliary drainage (n=3), surgical drainage (n=2). These interventions were in accordance with current international recommendations. There were no deaths and the mean length of stay was 10.3 days. PLA continues to carry significant morbidity. Demographics, including ethnicity, play an important role. Our tertiary centre cohort may account for higher incidence and better clinical outcomes.